PLAS 0826 stands out because virtually the entire public story happened in a two-day window. The Delaware series was formed in 2026, reports a first sale on September 2, and filed Form D on September 4 with exactly $100,000 offered, exactly $100,000 sold, $0 remaining and only one investor. It relies on Rule 506(b) and Section 3(c)(1), is classified as a private equity fund, does not intend the offering to last more than one year and reports no sales commissions or finder fees. This is materially different from an open-ended fundraise or a rolling syndicate: the filing looks like a pre-sized transaction vehicle whose required capital was known in advance and filled immediately.
The management chain gives the otherwise anonymous series a much more distinctive identity. Multifaceted Labs LLC, based at 211 Bowen Street in Providence, Rhode Island, is named as an executive officer, while Smaiyl Makyshov signs the filing as manager. Makyshov is independently identifiable as the founder and managing partner of Multifaceted Capital. Public profiles describe him as an emerging venture investor who moved from Kazakhstan to the United States, attended Phillips Exeter and Brown, then left university to pursue venture capital full time. Public reporting in 2026 said he initially raised roughly $225,000 for his first fund, later raised about $2.1 million for a subsequent vehicle and had backed more than 30 startups, with an investment thesis centered on founders from networks such as Y Combinator, a16z Speedrun and elite boarding-school communities. That background makes PLAS 0826 notably different from a generic administrator-created SPV because an identifiable emerging-manager strategy sits behind the filing even though the target company remains undisclosed.
The $4,500 related-person use-of-proceeds disclosure deserves special attention because it is unusually large relative to the vehicle. The Form D says the amount represents fund organizational and operating expenses. On a $100,000 offering, that equals 4.5% of gross proceeds before considering any other management economics, carried interest or underlying transaction costs that may exist outside Form D. Fixed legal, formation, accounting and administrative costs are common in small SPVs, but they can consume a much larger percentage of capital in a micro-vehicle than in a multimillion-dollar fund. Investors therefore need to distinguish the headline $100,000 raised from the amount actually available to purchase the underlying asset after formation expenses and any additional fees.
The largest remaining gap is the identity of the underlying investment. "PLAS 0826" is an internal series name rather than the name of a startup, and the Form D does not reveal whether the vehicle acquired preferred equity, common shares, a SAFE, convertible security, secondary stock or an interest in another fund. Multifaceted Capital's broader public investment activity includes early-stage technology companies and accelerator-linked founders, but those portfolio companies should not be attributed to this series without documentary evidence. The fact that other CGF2021 vehicles share the same Claymont address and administrative framework is likewise not enough to infer a common portfolio. Each series must be analyzed independently.
For investors, the economic analysis should therefore begin with the private deal memo rather than end with Form D. The essential questions are the name of the target company, round and valuation, security class, ownership percentage, whether the $100,000 represents gross or net investment capital, the exact fee and carry schedule, whether Multifaceted or another sponsor invests alongside the sole outside investor, what rights the series receives, and whether follow-on funding can be required. In a one-investor SPV, diversification is effectively absent at the vehicle level, so the outcome of a single startup or asset can determine nearly the entire return.
KEY FINDINGS AND SEC SNAPSHOT PLAS 0826 is a Delaware series of CGF2021 LLC, CIK 0002151223 and SEC file 021-596493. The Form D was filed September 4, 2026, two days after the September 2 first sale. It reports $100,000 offered, $100,000 sold, $0 remaining, one investor, $0 minimum investment, Rule 506(b), Section 3(c)(1), no sales commissions and no finder fees. The filing further discloses $4,500 of proceeds for related-person organizational and operating expenses. Multifaceted Labs LLC is the named executive officer and Smaiyl Makyshov is the manager and signatory.
MANAGER AND STRUCTURE PENETRATION Smaiyl Makyshov is independently associated with Multifaceted Capital as founder and managing partner, with public profiles describing a community-focused early-stage VC strategy and investments connected to startup networks including Y Combinator. Multifaceted Labs LLC's Providence address appears directly in the SEC filing, creating a clear manager-to-series identity chain. PLAS 0826 nevertheless remains legally and economically distinct from other CGF2021 series, and no verified public source was found identifying its underlying target company.
CORE DILIGENCE AND RISKS The key diligence questions are the underlying company or asset, purchase valuation, security class, gross versus net invested capital, fee and carry structure, ownership percentage, follow-on rights, dilution exposure, transfer restrictions and exit path. The single-investor structure creates extreme concentration, while the disclosed $4,500 organizational/operating allocation represents 4.5% of the entire offering and may create meaningful cost drag. Private-company valuation, liquidity and asymmetric-information risk remain high, and Multifaceted Capital's founder history or broader portfolio cannot substitute for deal-specific financial information.
PRIMARY EVIDENCE REVIEWED SEC Form D and EDGAR filing detail for PLAS 0826; SEC related-person and use-of-proceeds disclosures; public profiles identifying Smaiyl Makyshov as founder and managing partner of Multifaceted Capital; 2026 reporting on Multifaceted Capital's fundraising and startup portfolio; and other CGF2021 filings used only to understand the legal series framework, not to infer PLAS 0826's portfolio.
IMPORTANT FORM D NOTICE PLAS 0826's $100,000 amount sold is the gross amount of securities issued by the series, not the valuation of the underlying company and not necessarily the amount ultimately invested after expenses. The $4,500 disclosed for organizational and operating costs represents 4.5% of gross proceeds and should be reviewed alongside any additional private-document fees or carried interest. The underlying company is not identified in the public Form D, so FilingDossier does not assign a portfolio company without direct documentary evidence. Form D is an exempt-offering notice and does not constitute SEC approval of PLAS 0826, Multifaceted Labs, Multifaceted Capital or the investment.